Yonsei University
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Personality Characteristics and Compliance With Antiglaucoma Medication
- Conditions
- Glaucoma
- First Posted Date
- 2007-06-01
- Last Posted Date
- 2007-06-01
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 150
- Registration Number
- NCT00481494
- Locations
- π°π·
Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance Patients
Not Applicable
- Conditions
- Impaired Glucose ToleranceDiabetes
- First Posted Date
- 2007-05-11
- Last Posted Date
- 2007-05-11
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 182
- Registration Number
- NCT00472342
- Locations
- π°π·
Mi Young Lee, Wonju, Kangwon-Do, Korea, Republic of
Combination Therapy for Neovascular Age Related Macular Degeneration
Not Applicable
Withdrawn
- Conditions
- Macular Degeneration
- First Posted Date
- 2007-03-13
- Last Posted Date
- 2010-02-09
- Lead Sponsor
- Yonsei University
- Registration Number
- NCT00447031
- Locations
- π°π·
Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea, Republic of
Long-Term IOP Fluctuation and VF Progression After Triple Procedure
Completed
- Conditions
- GlaucomaFiltering SurgeryIntraocular Pressure
- First Posted Date
- 2007-01-30
- Last Posted Date
- 2007-01-30
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 300
- Registration Number
- NCT00428740
- Locations
- π°π·
Yonsei University College of Medicine, Seoul, Korea, Republic of
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
Not Applicable
Completed
- Conditions
- Diabetic Retinopathy
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2007-03-13
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 20
- Registration Number
- NCT00423059
- Locations
- π°π·
Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea, Republic of
Docetaxel and Epirubicin in Advanced Gastric Cancer
- First Posted Date
- 2006-09-14
- Last Posted Date
- 2014-03-03
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 34
- Registration Number
- NCT00375999
- Locations
- π°π·
Yongdong Severance Hospital, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath